Company Filing History:
Years Active: 2025
Title: Lixia Jin: Innovator in Immune Enhancing Drugs
Introduction
Lixia Jin is a notable inventor based in San Mateo, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of immune enhancing drugs. His innovative work focuses on methods for identifying compounds that can modulate biological processes related to immune responses.
Latest Patents
Lixia Jin holds 1 patent for his invention titled "Parenterally administered immune enhancing drugs." This patent describes methods for identifying compounds that modulate the conversion of AMP to adenosine by 5'-nucleotidase, ecto. The compounds possess specific pharmacokinetic characteristics and are aimed at treating and preventing a variety of diseases, including cancer and immune-related disorders.
Career Highlights
Lixia Jin is currently associated with Arcus Biosciences, Inc., where he continues to advance his research in immune therapies. His work has the potential to impact the treatment landscape for various health conditions significantly.
Collaborations
Lixia collaborates with talented professionals in his field, including Juan Carlos Jaen and Jenna Leigh Jeffrey. Their combined expertise fosters an environment of innovation and progress in the development of new therapeutic solutions.
Conclusion
Lixia Jin's contributions to the field of immune enhancing drugs exemplify the importance of innovation in healthcare. His work not only advances scientific understanding but also holds promise for improving patient outcomes in the treatment of complex diseases.